Identification Generic Name (2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol DrugBank Accession Number DB07750 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol (DB07750) ×  Close Weight Average: 448.346  Monoisotopic: 447.122880419  Chemical Formula C 21 H 23 Cl 2 N 5 O 2 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Cyclin-dependent kinase 2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as dichlorobenzenes. These are compounds containing a benzene with exactly two chlorine atoms attached to it. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Halobenzenes Direct Parent Dichlorobenzenes Alternative Parents Aniline and substituted anilines  /  Phenoxy compounds  /  Phenol ethers  /  Alkyl aryl ethers  /  Aminopyrimidines and derivatives  /  Aryl chlorides  /  Imidolactams  /  Heteroaromatic compounds  /  Trialkylamines  /  1,2-aminoalcohols  /  Secondary alcohols  /  Azacyclic compounds  /  Secondary amines  /  Hydrocarbon derivatives  /  Organochlorides  /  Organopnictogen compounds 
 
 
  show 6 more Substituents 1,2-aminoalcohol  /  1,4-dichlorobenzene  /  Alcohol  /  Alkyl aryl ether  /  Amine  /  Aminopyrimidine  /  Aniline or substituted anilines  /  Aromatic heteromonocyclic compound  /  Aryl chloride  /  Aryl halide  /  Azacycle  /  Ether  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidolactam  /  Organic nitrogen compound  /  Organic oxygen compound  /  Organochloride  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Phenol ether  /  Phenoxy compound  /  Pyrimidine  /  Secondary alcohol  /  Secondary amine  /  Tertiary aliphatic amine  /  Tertiary amine 
 
 
  show 20 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors aminopyrimidine, dichlorobenzene ( CHEBI:47405 )  Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key GNLAGGCSJGJECE-MRXNPFEDSA-N InChI InChI=1S/C21H23Cl2N5O2/c1-28(2)12-16(29)13-30-17-6-4-15(5-7-17)25-21-24-10-9-20(27-21)26-19-11-14(22)3-8-18(19)23/h3-11,16,29H,12-13H2,1-2H3,(H2,24,25,26,27)/t16-/m1/s1 IUPAC Name (2R)-1-[4-({4-[(2,5-dichlorophenyl)amino]pyrimidin-2-yl}amino)phenoxy]-3-(dimethylamino)propan-2-ol SMILES [H]N(C1=CC=C(OC[C@H](O)CN(C)C)C=C1)C1=NC=CC(=N1)N([H])C1=C(Cl)C=CC(Cl)=C1 References General References Not Available External Links PubChem Compound 445952 PubChem Substance 99444221 ChemSpider 393432 ZINC ZINC000000602494 PDBe Ligand FAL PDB Entries 1h01 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.02 mg/mL ALOGPS logP 4.38 ALOGPS logP 4.64 Chemaxon logS -4.4 ALOGPS pKa (Strongest Acidic) 13.76 Chemaxon pKa (Strongest Basic) 8.7 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 7 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 82.54 Å 2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 120.01 m 3 ·mol -1 Chemaxon Polarizability 47.26 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9689 Blood Brain Barrier - 0.5075 Caco-2 permeable + 0.522 P-glycoprotein substrate Substrate 0.6666 P-glycoprotein inhibitor I Non-inhibitor 0.7073 P-glycoprotein inhibitor II Inhibitor 0.9174 Renal organic cation transporter Non-inhibitor 0.7376 CYP450 2C9 substrate Non-substrate 0.823 CYP450 2D6 substrate Non-substrate 0.793 CYP450 3A4 substrate Substrate 0.5622 CYP450 1A2 substrate Non-inhibitor 0.5124 CYP450 2C9 inhibitor Non-inhibitor 0.774 CYP450 2D6 inhibitor Non-inhibitor 0.5488 CYP450 2C19 inhibitor Non-inhibitor 0.6217 CYP450 3A4 inhibitor Non-inhibitor 0.6943 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5917 Ames test Non AMES toxic 0.6503 Carcinogenicity Non-carcinogens 0.8644 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.3546 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.74 hERG inhibition (predictor II) Inhibitor 0.5861    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Cyclin-dependent kinase 2 Kind Protein Organism Humans Pharmacological action Unknown General Function Metal ion binding Specific Function Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N... Gene Name CDK2 Uniprot ID P24941 Uniprot Name Cyclin-dependent kinase 2 Molecular Weight 33929.215 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52 